These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 17846258

  • 1. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators.
    Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
    [Abstract] [Full Text] [Related]

  • 2. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J, Barkin RL.
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [Abstract] [Full Text] [Related]

  • 4. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS, Ng F, Berk M.
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [Abstract] [Full Text] [Related]

  • 5. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [Abstract] [Full Text] [Related]

  • 6. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H, Aghayan S, Jalili SA, Akhondzadeh S, Yahyazadeh O, Pakravan-Nejad M.
    J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
    [Abstract] [Full Text] [Related]

  • 7. Treatment of depression--newer pharmacotherapies.
    Mulrow CD, Williams JW, Trivedi M, Chiquette E, Aguilar C, Cornell JE, Badgett R, Noël PH, Lawrence V, Lee S, Luther M, Ramirez G, Richardson WS, Stamm K.
    Psychopharmacol Bull; 1998 Apr; 34(4):409-795. PubMed ID: 10513454
    [Abstract] [Full Text] [Related]

  • 8. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H, Mirtazapine in the Nursing Home Study Group.
    Curr Med Res Opin; 2003 Apr; 19(8):737-46. PubMed ID: 14687445
    [Abstract] [Full Text] [Related]

  • 9. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT, Glaudin V, Panagides J, Gilvary E.
    Psychopharmacol Bull; 1990 Apr; 26(2):191-6. PubMed ID: 2236455
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA, Masand PS, Pae CU, Peindl K, Hooper-Wood C, Mannelli P, Ciccone P.
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [Abstract] [Full Text] [Related]

  • 11. Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).
    van den Brink RH, van Melle JP, Honig A, Schene AH, Crijns HJ, Lambert FP, Ormel J.
    Am Heart J; 2002 Aug; 144(2):219-25. PubMed ID: 12177637
    [Abstract] [Full Text] [Related]

  • 12. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J.
    Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
    [Abstract] [Full Text] [Related]

  • 13. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K, Chrzanowski W, Schmitz M, Savela A, Milanova V, Gee M, Krishen A, Millen L, Leary MO, Modell J.
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [Abstract] [Full Text] [Related]

  • 14. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD, Kundhur D, Solomons K, Yatham LN, Lam RW.
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [Abstract] [Full Text] [Related]

  • 15. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
    Kang EH, Lee IS, Chung SK, Lee SY, Kim EJ, Hong JP, Oh KS, Woo JM, Kim S, Park JE, Yu BH.
    Psychiatry Res; 2009 Sep 30; 169(2):118-23. PubMed ID: 19695711
    [Abstract] [Full Text] [Related]

  • 16. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M, Kopecek M, Novak T, Stopkova P, Sos P, Kozeny J, Brunovsky M, Höschl C.
    J Affect Disord; 2009 Nov 30; 118(1-3):94-100. PubMed ID: 19249105
    [Abstract] [Full Text] [Related]

  • 17. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
    Varia I, Venkataraman S, Hellegers C, Gersing K, Doraiswamy PM.
    Psychopharmacol Bull; 2007 Nov 30; 40(1):47-56. PubMed ID: 17285095
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT.
    Int Clin Psychopharmacol; 1999 Nov 30; 14(6):329-37. PubMed ID: 10565799
    [Abstract] [Full Text] [Related]

  • 19. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
    Baldwin D, Bridgman K, Buis C.
    J Psychopharmacol; 2006 Jan 30; 20(1):91-6. PubMed ID: 16204325
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB, Thase ME, EPIC 014 Study Group.
    J Psychiatr Res; 2007 Jan 30; 41(3-4):351-9. PubMed ID: 16165158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.